Imidazole dipeptides — mainly anserine and carnosine — are a Japan-originated fatigue ingredient, usually sourced from chicken breast extract. They are widely notified as Foods with Function Claims in Japan, and brands abroad ask for a Japan-made version because the ingredient’s home-market research base is unusually deep for a food-derived peptide.
This guide is for brand owners planning an oral imidazole dipeptide product made in Japan. It covers what the human trials show, who ran and funded them, what Japanese products are allowed to say, how the ingredient is usually formulated, and what to fix before asking for a quotation.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning an imidazole dipeptide product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
Small Japanese randomised trials report lower everyday fatigue scores with chicken breast extract imidazole dipeptides than with placebo, but the underlying trial reports are hard to verify independently and several were run by researchers linked to the ingredient’s own research and clinic network.
| Study | Design | Reported result |
|---|---|---|
| Nishitani et al., review, Japanese Journal of Complementary and Alternative Medicine 2009, 6(3):123–129 (DOI 10.1625/jcam.6.123) | Narrative review of two Japanese human trials of chicken breast extract imidazole dipeptides (carnosine and anserine), one on fatigue from physical exertion and one on fatigue from daily activity | Both trials are reported as showing lower fatigue outcomes with imidazole dipeptide intake than with placebo |
Three points matter here:
- Industry linkage. The 2009 review’s own author list includes staff of a private clinic and a company R&D division alongside two university medical schools. That does not make the findings wrong, but it means this is not arm’s-length independent research.
- Indexing. The underlying trial reports were published in a Japanese-language pharmacology journal that is not indexed in PubMed. The 2009 review summarises them; ask your ingredient supplier for the original trial reports before you cite them.
- Scope. These are small trials in healthy adults reporting everyday tiredness, not a disease population, and the outcome measure is a self-reported fatigue scale, not a physical performance test in most of them.
Checked against the published abstracts on 25 September 2026.
What Japanese products say
Imidazole dipeptide is a real, currently active Foods with Function Claims ingredient in Japan, notified for easing temporary, everyday fatigue.
Under Japan’s Foods with Function Claims system, the notifying business is responsible for the scientific evidence behind its stated function and submits it to the Consumer Affairs Agency before sale. One notified imidazole dipeptide product carries wording to the effect that imidazole dipeptide has been reported to reduce temporary fatigue in daily life. The research review behind that notification covered three Japanese studies in healthy adults, all using drinks at 200–400 mg a day, with significant results in the two studies at 400 mg a day and only a trend in the third. Treat this as one example of the wording pattern, not a survey of every notification.
Two lessons for a brand abroad:
- The Japanese wording is deliberately modest. It speaks of temporary, everyday fatigue from daily life, not stamina, endurance or any medical form of exhaustion. Copying it into stronger language in your own market goes beyond what either the notifications or the underlying trials support.
- A Japanese notification is not a global endorsement. It is a Japanese regulatory mechanism for products sold in Japan, built on evidence the notifying business selected and submitted. Your label abroad follows your own market’s rules and its own evidence standard.
💬 Need an evidence summary for your regulatory adviser that separates the Japanese notification wording from the underlying trials? We prepare it with the manufacturing documents. Tell us your market.
Wording that stays on safe ground
Describe imidazole dipeptide by the everyday state it has been studied for, and say plainly that the evidence base is small and largely Japanese.
| Safer wording | Wording to avoid |
|---|---|
| ”Studied for everyday fatigue from daily activity" | "Boosts energy”, “cures exhaustion”, or any reference to chronic fatigue syndrome |
| ”Contains 200–400 mg imidazole dipeptide per daily serving" | "Clinically proven” without naming the study, its size and its funding |
| ”Sourced from chicken breast extract” | Implying the research is independent of the ingredient’s own industry when it is not |
How imidazole dipeptides are formulated
Imidazole dipeptides from chicken breast extract are a water-soluble small-peptide powder, dosed in the low hundreds of milligrams, which is why Japan uses the ingredient in capsules, tablets, drinks and powder sticks alike.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Hard capsule or tablet | Small daily serving at 200–400 mg, low cost per day | Taste of the extract is mild but can need masking in chewables |
| Drink or ready-to-drink shot | Matches the format used in the Japanese trials and notified products | Extract has a savoury, meat-derived note that formulation needs to manage |
| Powder stick | Flexible dosing, mixes into water or other drinks | Solubility and taste at higher concentrations |
| Combined sports or energy formula | Pairs with amino acids, vitamins or citrate blends | Every companion ingredient needs its own Japanese food-law check |
Decisions that shape the specification:
- Source and standardisation. The material is an extract of chicken breast, standardised for combined anserine and carnosine content. Ask the supplier for the assay method and the guaranteed imidazole dipeptide content per gram of extract.
- Daily amount. Match the amount to the trial you intend to cite; the studies behind one Japanese notification used 200–400 mg a day.
- Dietary suitability. Because the source is chicken, the ingredient is not suitable for vegetarian, vegan, halal-without-certification or kosher-without-certification claims unless the supplier can document the relevant certification for that specific extract.
- Companion ingredients. Sport and energy formulas often add other amino acids or vitamins; each one needs its own check against Japanese food law before the whole formula can be finalised.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
Chicken breast extract itself is a long-established Japanese food ingredient. The companion ingredients in an energy or sports formula are usually where a problem shows up — some amino acids, plant extracts or stimulant-adjacent ingredients sold freely elsewhere are treated as medicines in Japan and would stop the whole product being made as a food there. See the Japan-made supplement OEM page, and compare with our GABA and astaxanthin guides, which cover similar everyday-state, industry-adjacent evidence in more depth.
Before you ask for a quotation
A factory can quote accurately once the amount, the form, the companions and the packaging are fixed.
- Imidazole dipeptide amount per serving and servings per pack
- Dosage form, and flavour approach for the meat-derived extract note
- Companion ingredients and their amounts
- Any dietary claim you want (and the certification it needs)
- Packaging
- Countries you will sell in, and first order and annual volume
💬 Ready to design a Japan-made imidazole dipeptide product? Send us the concept — amount, form, companion ingredients and the countries you will sell in.
Frequently asked questions
1. Is there strong evidence that imidazole dipeptides reduce fatigue?
Small Japanese randomised trials, summarised in a 2009 review, report lower everyday fatigue scores than placebo. The trials are small, mostly Japanese, and some were run by researchers linked to the ingredient’s own research and clinic network, so describe the ingredient as studied for everyday fatigue rather than as a proven remedy.
2. Why are the trials hard to find in international databases?
The underlying trial reports were published in a Japanese-language pharmacology journal that is not indexed in PubMed. A 2009 review summarises them. Ask your ingredient supplier for the original reports before you cite them.
3. What does the Japanese Foods with Function Claims wording actually say?
In one notification, the wording is to the effect that imidazole dipeptide has been reported to reduce temporary fatigue in daily life — not stamina, endurance or any medical condition. Other notifications may word it differently.
4. Is imidazole dipeptide suitable for a vegetarian or halal claim?
Not by default. It is an extract of chicken breast, so vegetarian, vegan, halal or kosher claims need supplier documentation and certification specific to that extract batch.
5. What dose should I use?
Match it to the evidence you plan to cite. The studies behind one Foods with Function Claims notification used 200–400 mg a day, with significant results at 400 mg.
Sources: “Novel Anti-Fatigue Compound: Imidazole Dipeptide”, Nishitani M, Munekiyo Y, Sugino T, Kajimoto O, Japanese Journal of Complementary and Alternative Medicine 2009, 6(3):123–129, DOI 10.1625/jcam.6.123; “Influence of Imidazole-Dipeptides on Cognitive Status and Preservation in Elders: A Narrative Review”, Masuoka N, Lei C, Li Y, Hisatsune T, Nutrients 2021, 13(2):397, PMID 33513893; Consumer Affairs Agency Foods with Function Claims notifications. Checked on 25 September 2026.